CID 89860551

Conteltinib

Structural Information

Molecular Formula
C32H45N9O3S
SMILES
CC(C)NS(=O)(=O)C1=CC=CC=C1NC2=NC(=NC3=C2CCN3)NC4=C(C=C(C=C4)N5CCC(CC5)N6CCN(CC6)C)OC
InChI
InChI=1S/C32H45N9O3S/c1-22(2)38-45(42,43)29-8-6-5-7-27(29)34-31-25-11-14-33-30(25)36-32(37-31)35-26-10-9-24(21-28(26)44-4)40-15-12-23(13-16-40)41-19-17-39(3)18-20-41/h5-10,21-23,38H,11-20H2,1-4H3,(H3,33,34,35,36,37)
InChIKey
NPJCURIANJMFEO-UHFFFAOYSA-N
Compound name
2-[[2-[2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]anilino]-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl]amino]-N-propan-2-ylbenzenesulfonamide
Related CIDs

2D Structure

compound 2d structure
3
Annotation Hits

3
References

184
Patents

635.3366 Da
Monoisotopic Mass

5.1
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 636.34388 240.0
[M+Na]+ 658.32582 239.6
[M-H]- 634.32932 245.7
[M+NH4]+ 653.37042 233.8
[M+K]+ 674.29976 231.8
[M+H-H2O]+ 618.33386 227.3
[M+HCOO]- 680.33480 240.2
[M+CH3COO]- 694.35045 240.3
[M+Na-2H]- 656.31127 238.5
[M]+ 635.33605 233.9
[M]- 635.33715 233.9
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe